SGTI Signs LicensingAgreement for Sytrinol

SGTI Signs LicensingAgreement for Sytrinol

CHICAGO & LOS ANGELESSourceOne Global Partners signed asub-licensing agreement with Soft Gel Technologies Inc. (SGTI) that allows SGTI to provide contract manufacturing services forSytrinol in a soft gel delivery system for the U.S. market. SourceOnelicensed the exclusive worldwide distribution rights to market Sytrinol indietary supplements from London, Ontario-based KGK Synergize.

This sub-license agreement is important for brand marketers that chooseSytrinol in a soft gel and do not have their own manufacturing facilities,said Jesse Lopez, president and chief executive officer (CEO) of SourceOne(www.source-1-global.com). SGTI has a superior and proven track record ofhelping to build awareness of the branded ingredients in its soft gels. Thissub-license agreement affords SGTI with limited exclusivity for delivering theheart health benefits of Sytrinol in a soft gelatin form.

Ron Udell, president of SGTI, noted, This alliance with SourceOne and itsnovel compound Sytrinol will provide brand marketers and consumers with thebenefit of choice to consume a high-quality product for heart health in aneasy-toswallow soft gel.